Literature DB >> 11167801

Large granular lymphocyte leukaemia is characterized by a clonal T-cell receptor rearrangement in both memory and effector CD8(+) lymphocyte populations.

J J Melenhorst1, L Sorbara, M Kirby, N F Hensel, A J Barrett.   

Abstract

Large granular lymphocyte (LGL) leukaemia is a disease with increased numbers of circulating granular lymphocytes and an increased percentage of clonally rearranged CD8(+)CD57(+) cells. To determine whether LGL cells are also found in other lymphocyte subsets, CD8(+) cells from 10 LGL patients were sorted into CD57(+) and CD57(-) fractions and analysed for clonality using a T-cell receptor gamma (TCR gamma) polymerase chain reaction (PCR). In nine patients, a clonal TCR rearrangement was identified in the CD8(+)CD57(+) cells, and in one patient, the TCR rearrangement was oligoclonal in the CD8(+)CD57(+) fraction. In eight out of nine of the clonally rearranged patients, the same band was also present in the CD8(+)CD57(-) fraction. To define the relationship between CD57(-) and CD57(+) LGL populations, CD8(+)CD57(-) and CD8(+)CD57(+) cells were sorted from five patients and cultured in the presence of anti-CD3 plus CD28 antibodies. The CD57(+) cells died of apoptosis before d 7, while the CD57(-) cells proliferated and differentiated into CD57(+) cells. Clonal analysis identified the same band in both cultured subpopulations and in the uncultured CD8(+) cells. Immunophenotypical analysis showed that CD8(+)CD57(-) cells expressed memory cell markers, while the CD8(+)CD57(+) cells exhibited effector characteristics. These results suggest that LGL disease originates in a CD57(-) memory T-cell compartment that continually generates CD57(+) (effector cell) progeny.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11167801     DOI: 10.1046/j.1365-2141.2001.02509.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  12 in total

1.  Phosphatidylinositol-3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis.

Authors:  Andrew E Schade; Jennifer J Powers; Marcin W Wlodarski; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2006-02-16       Impact factor: 22.113

2.  Clonotype analysis of cytomegalovirus-specific cytotoxic T lymphocytes.

Authors:  Nina Babel; Gordon Brestrich; Lukasz P Gondek; Arne Sattler; Marcin W Wlodarski; Nina Poliak; Nicole Bethke; Andreas Thiel; Markus H Hammer; Petra Reinke; Jaroslaw P Maciejewski
Journal:  J Am Soc Nephrol       Date:  2008-09-17       Impact factor: 10.121

3.  Seroreactivity to LGL leukemia-specific epitopes in aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria: results of a bone marrow failure consortium study.

Authors:  Susan Bell Nyland; Daniel J Krissinger; Michael J Clemente; Rosalyn B Irby; Kendall Thomas Baab; Nancy Ruth Jarbadan; Lubomir Sokol; Eric Schaefer; Jason Liao; David Cuthbertson; Pearlie Epling-Burnette; Ronald Paquette; Alan F List; Jaroslaw P Maciejewski; Thomas P Loughran
Journal:  Leuk Res       Date:  2012-03-02       Impact factor: 3.156

4.  Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia.

Authors:  Jun Yang; P K Epling-Burnette; Jeffrey S Painter; Jianxiang Zou; Fanqi Bai; Sheng Wei; Thomas P Loughran
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

5.  Close resemblance between chemokine receptor expression profiles of lymphoproliferative disease of granular lymphocytes and their normal counterparts in association with elevated serum concentrations of IP-10 and MIG.

Authors:  Kayoko Momose; Hideki Makishima; Toshiro Ito; Hideyuki Nakazawa; Shigetaka Shimodaira; Kendo Kiyosawa; Fumihiro Ishida
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

6.  TCRalphabeta+/CD4+ large granular lymphocytosis: a new clonal T-cell lymphoproliferative disorder.

Authors:  Margarida Lima; Julia Almeida; Maria Dos Anjos Teixeira; Maria del Carmen Alguero Md; Ana Helena Santos; Ana Balanzategui; Maria Luís Queirós; Paloma Bárcena; Antonio Izarra; Sónia Fonseca; Clara Bueno; Benvindo Justiça; Marcos Gonzalez; Jesús F San Miguel; Alberto Orfao
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

7.  Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes.

Authors:  Mithun Vinod Shah; Ranran Zhang; Rosalyn Irby; Ravi Kothapalli; Xin Liu; Ty Arrington; Bryan Frank; Norman H Lee; Thomas P Loughran
Journal:  Blood       Date:  2008-05-13       Impact factor: 22.113

8.  TRAIL mediates and sustains constitutive NF-κB activation in LGL leukemia.

Authors:  Jun Yang; Francis R LeBlanc; Shubha A Dighe; Cait E Hamele; Thomas L Olson; David J Feith; Thomas P Loughran
Journal:  Blood       Date:  2018-04-26       Impact factor: 22.113

9.  A case of CD4(+)T-cell large granular lymphocytic leukemia.

Authors:  Jaewook Kim; Chan Jeoung Park; Seongsoo Jang; Young-Uk Cho; Sang Hyuk Park; Eul-Ju Seo; Hyun-Sook Chi; Cheolwon Suh
Journal:  Ann Lab Med       Date:  2013-04-17       Impact factor: 3.464

10.  Identification of human viral protein-derived ligands recognized by individual MHCI-restricted T-cell receptors.

Authors:  Barbara Szomolay; Jie Liu; Paul E Brown; John J Miles; Mathew Clement; Sian Llewellyn-Lacey; Garry Dolton; Julia Ekeruche-Makinde; Anya Lissina; Andrea J Schauenburg; Andrew K Sewell; Scott R Burrows; Mario Roederer; David A Price; Linda Wooldridge; Hugo A van den Berg
Journal:  Immunol Cell Biol       Date:  2016-02-05       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.